276 related articles for article (PubMed ID: 17137902)
41. Biomarkers of chronic uveitis in juvenile idiopathic arthritis: predictive value of antihistone antibodies and antinuclear antibodies.
Nordal EB; Songstad NT; Berntson L; Moen T; Straume B; Rygg M
J Rheumatol; 2009 Aug; 36(8):1737-43. PubMed ID: 19567622
[TBL] [Abstract][Full Text] [Related]
42. Use of tumor necrosis factor inhibitors in uveitis.
Rabinovich CE
Curr Opin Rheumatol; 2007 Sep; 19(5):482-6. PubMed ID: 17762615
[TBL] [Abstract][Full Text] [Related]
43. Long-term follow-up of patients with uveitis associated with juvenile idiopathic arthritis: a cohort study.
Skarin A; Elborgh R; Edlund E; Bengtsson-Stigmar E
Ocul Immunol Inflamm; 2009; 17(2):104-8. PubMed ID: 19412872
[TBL] [Abstract][Full Text] [Related]
44. [Anterior uveitis and juvenile idiopathic arthritis].
Vela JI; Galán A; Fernández E; Romera M; Torres JJ
Arch Soc Esp Oftalmol; 2003 Oct; 78(10):561-5. PubMed ID: 14569505
[TBL] [Abstract][Full Text] [Related]
45. Hodgkin's lymphoma and tumor necrosis factor inhibitors in juvenile idiopathic arthritis.
Yildirim-Toruner C; Kimura Y; Rabinovich E
J Rheumatol; 2008 Aug; 35(8):1680-1. PubMed ID: 18671328
[No Abstract] [Full Text] [Related]
46. Male gender as a risk factor for complications in uveitis associated with juvenile idiopathic arthritis.
Kalinina Ayuso V; Ten Cate HA; van der Does P; Rothova A; de Boer JH
Am J Ophthalmol; 2010 Jun; 149(6):994-999.e5. PubMed ID: 20510688
[TBL] [Abstract][Full Text] [Related]
47. Occurrence of adverse events in patients with JIA receiving biologic agents: long-term follow-up in a real-life setting.
Tarkiainen M; Tynjälä P; Vähäsalo P; Lahdenne P
Rheumatology (Oxford); 2015 Jul; 54(7):1170-6. PubMed ID: 25504896
[TBL] [Abstract][Full Text] [Related]
48. Timing of uveitis onset in oligoarticular juvenile idiopathic arthritis (JIA) is the main predictor of severe course uveitis.
Zannin ME; Buscain I; Vittadello F; Martini G; Alessio M; Orsoni JG; Breda L; Rigante D; Cimaz R; Zulian F
Acta Ophthalmol; 2012 Feb; 90(1):91-5. PubMed ID: 20039849
[TBL] [Abstract][Full Text] [Related]
49. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.
Horneff G; De Bock F; Foeldvari I; Girschick HJ; Michels H; Moebius D; Schmeling H;
Ann Rheum Dis; 2009 Apr; 68(4):519-25. PubMed ID: 18413440
[TBL] [Abstract][Full Text] [Related]
50. Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab).
Heiligenhaus A; Miserocchi E; Heinz C; Gerloni V; Kotaniemi K
Rheumatology (Oxford); 2011 Aug; 50(8):1390-4. PubMed ID: 21378109
[TBL] [Abstract][Full Text] [Related]
51. Optic neuritis associated with etanercept therapy in two patients with extended oligoarticular juvenile idiopathic arthritis.
Tauber T; Daniel D; Barash J; Turetz J; Morad Y
Rheumatology (Oxford); 2005 Mar; 44(3):405. PubMed ID: 15637094
[No Abstract] [Full Text] [Related]
52. [Efficacy of etanercept in the treatment of juvenile idiopathic arthritis].
de Inocencio Arocena J; Merino Muñoz R; Alvarez Madrid C; García-Consuegra Molina J
An Pediatr (Barc); 2009 Apr; 70(4):354-61. PubMed ID: 19324597
[TBL] [Abstract][Full Text] [Related]
53. Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry.
Zannin ME; Birolo C; Gerloni VM; Miserocchi E; Pontikaki I; Paroli MP; Bracaglia C; Shardlow A; Parentin F; Cimaz R; Simonini G; Falcini F; Corona F; Viola S; De Marco R; Breda L; La Torre F; Vittadello F; Martini G; Zulian F
J Rheumatol; 2013 Jan; 40(1):74-9. PubMed ID: 23118110
[TBL] [Abstract][Full Text] [Related]
54. Methotrexate therapy may prevent the onset of uveitis in juvenile idiopathic arthritis.
Papadopoulou C; Kostik M; Böhm M; Nieto-Gonzalez JC; Gonzalez-Fernandez MI; Pistorio A; Martini A; Ravelli A
J Pediatr; 2013 Sep; 163(3):879-84. PubMed ID: 23664559
[TBL] [Abstract][Full Text] [Related]
55. Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations.
Foell D; Wittkowski H; Hammerschmidt I; Wulffraat N; Schmeling H; Frosch M; Horneff G; Kuis W; Sorg C; Roth J
Arthritis Rheum; 2004 Apr; 50(4):1286-95. PubMed ID: 15077313
[TBL] [Abstract][Full Text] [Related]
56. Male gender and poor visual outcome in uveitis associated with juvenile idiopathic arthritis.
Kalinina Ayuso V; Ten Cate HA; van der Does P; Rothova A; de Boer JH
Am J Ophthalmol; 2010 Jun; 149(6):987-93. PubMed ID: 20417926
[TBL] [Abstract][Full Text] [Related]
57. [The clinical feature, diagnosis and treatment of uveitis associated with juvenile chronic arthritis].
Zhang Z; Yang PZ; Zhou HY; Yu Q; Huang XK; Li B
Zhonghua Yan Ke Za Zhi; 2005 Apr; 41(4):346-9. PubMed ID: 15924698
[TBL] [Abstract][Full Text] [Related]
58. Long-term outcome and prognosis in oligoarticular-onset juvenile idiopathic arthritis.
Guillaume S; Prieur AM; Coste J; Job-Deslandre C
Arthritis Rheum; 2000 Aug; 43(8):1858-65. PubMed ID: 10943877
[TBL] [Abstract][Full Text] [Related]
59. A prospective population based study on outcome of juvenile chronic arthritis in Costa Rica.
Arguedas O; Fasth A; Andersson-Gäre B
J Rheumatol; 2002 Jan; 29(1):174-83. PubMed ID: 11824957
[TBL] [Abstract][Full Text] [Related]
60. [Diagnosis of rheumatoid uveitis in children and teenagers].
Denislam D; Constantin F
Oftalmologia; 2005; 49(2):75-81. PubMed ID: 16245748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
